Cite

    Schaefer, B. et al. (2020). Impact of exogenous antithrombin on low molecular weight heparin anti‐Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels. Pediatric blood & cancer. 67 (11), p. n/a. [Online].